Does insulin preserve beta-cell function in type 2 diabetes?
作者信息
Heise T, Sawicki P T
出版信息
J Intern Med. 2002 Apr;251(4):283-5. doi: 10.1046/j.1365-2796.2002.00965.x.
Abstract
摘要
相似文献
1
Does insulin preserve beta-cell function in type 2 diabetes?
J Intern Med. 2002 Apr;251(4):283-5. doi: 10.1046/j.1365-2796.2002.00965.x.
2
Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part I--"The pros".
Horm Metab Res. 1996 Sep;28(9):517-21. doi: 10.1055/s-2007-979844.
3
[Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].
Pol Tyg Lek. 1985 May 6;40(18):505-11.
4
Mechanism of action of sulphonylureas with special reference to the extrapancreatic effect: an overview.
Diabet Med. 1988 Oct;5(7):613-20. doi: 10.1111/j.1464-5491.1988.tb01068.x.
5
Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.
Pharmacotherapy. 2004 May;24(5):606-20. doi: 10.1592/phco.24.6.606.34752.
6
A 12-h intravenous insulin infusion restores the beta-cell response torpidity to sulfonylureas in patients affected by type 2 diabetes.
Diabetes Care. 2000 Dec;23(12):1857-8. doi: 10.2337/diacare.23.12.1857.
7
Cardiovascular effects of sulphonylureas: role of K(ATP) channels.
Diabetes Obes Metab. 2000 Apr;2(2):67-73. doi: 10.1046/j.1463-1326.2000.00047.x.
8
The place of sulfonylureas in the therapy for type 2 diabetes mellitus.
Metabolism. 2006 May;55(5 Suppl 1):S20-7. doi: 10.1016/j.metabol.2006.02.003.
9
Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
Metabolism. 2006 May;55(5 Suppl 1):S2-5. doi: 10.1016/j.metabol.2006.02.006.
10
Type 2 diabetes and insulin secretagogues.
J Clin Endocrinol Metab. 2012 Mar;97(3):37A-38A. doi: 10.1210/jcem.97.3.zeg37a.
Zotero 插件